Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer updates include removal of HHS Vulnerability Disclosure and addition of Revision: v3.3.3; these are minor site maintenance updates and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:31:47.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page. No visible changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the warning about lapses in government funding and potential delays in updates from the page, while the study details content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:18:57.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Core study content appears unchanged; the screenshots show only minor UI/layout adjustments that do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:42.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T06:36:13.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Updated page version from v3.0.2 to v3.1.0, adding new identifiers and contact emails, indicating a revision of core content and metadata.
    Difference
    0.1%
    Check dated 2025-09-29T03:14:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.